180 related articles for article (PubMed ID: 1377676)
1. A panel of monoclonal antibodies for the type I insulin-like growth factor receptor. Epitope mapping, effects on ligand binding, and biological activity.
Soos MA; Field CE; Lammers R; Ullrich A; Zhang B; Roth RA; Andersen AS; Kjeldsen T; Siddle K
J Biol Chem; 1992 Jun; 267(18):12955-63. PubMed ID: 1377676
[TBL] [Abstract][Full Text] [Related]
2. Growth-stimulatory monoclonal antibodies against human insulin-like growth factor I receptor.
Xiong L; Kasuya J; Li SL; Kato J; Fujita-Yamaguchi Y
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5356-60. PubMed ID: 1319060
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to the type 1 insulin-like growth factor and insulin receptors stimulates deoxyribonucleic acid synthesis in human and murine fibroblasts.
Cara JF; Stuart CA; Furlanetto RW
Endocrinology; 1988 Sep; 123(3):1341-7. PubMed ID: 2969801
[TBL] [Abstract][Full Text] [Related]
4. Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors.
Soos MA; Siddle K
Biochem J; 1989 Oct; 263(2):553-63. PubMed ID: 2480779
[TBL] [Abstract][Full Text] [Related]
5. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells.
Soos MA; Whittaker J; Lammers R; Ullrich A; Siddle K
Biochem J; 1990 Sep; 270(2):383-90. PubMed ID: 1698059
[TBL] [Abstract][Full Text] [Related]
6. Expression of a type I insulin-like growth factor receptor with low affinity for insulin-like growth factor II.
Germain-Lee EL; Janicot M; Lammers R; Ullrich A; Casella SJ
Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):413-7. PubMed ID: 1310594
[TBL] [Abstract][Full Text] [Related]
7. Identification of the insulin-like growth factor I (IGF I) epitopes recognized by monoclonal and polyclonal antibodies to IGF I.
Cascieri MA; Bayne ML; Ber E; Green BG; Men GW; Chicchi GG
Endocrinology; 1990 Jun; 126(6):2773-7. PubMed ID: 1693561
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the monoclonal antibodies alpha IR-1 and alpha IR-3 with insulin and somatomedin-C receptors.
Jacobs S; Cook S; Svoboda ME; Van Wyk JJ
Endocrinology; 1986 Jan; 118(1):223-6. PubMed ID: 2416553
[TBL] [Abstract][Full Text] [Related]
9. Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.
Soos MA; Field CE; Siddle K
Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):419-26. PubMed ID: 8452530
[TBL] [Abstract][Full Text] [Related]
10. Identification of a monoclonal antibody which can distinguish between two distinct species of the type I receptor for insulin-like growth factor.
Morgan DO; Roth RA
Biochem Biophys Res Commun; 1986 Aug; 138(3):1341-7. PubMed ID: 3019341
[TBL] [Abstract][Full Text] [Related]
11. Insulin and insulin-like growth factor-1 binding specificity is determined by distinct regions of their cognate receptors.
Schumacher R; Mosthaf L; Schlessinger J; Brandenburg D; Ullrich A
J Biol Chem; 1991 Oct; 266(29):19288-95. PubMed ID: 1655782
[TBL] [Abstract][Full Text] [Related]
12. Characterization of monoclonal antibodies to the IGF-I receptor that inhibit IGF-I binding to human cells.
Flier JS; Moses AC
Biochem Biophys Res Commun; 1985 Mar; 127(3):929-36. PubMed ID: 2580525
[TBL] [Abstract][Full Text] [Related]
13. High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.
Milazzo G; Yip CC; Maddux BA; Vigneri R; Goldfine ID
J Clin Invest; 1992 Mar; 89(3):899-908. PubMed ID: 1311720
[TBL] [Abstract][Full Text] [Related]
14. Insulin and insulinlike growth factor 1 (IGF-1) receptors during central nervous system development: expression of two immunologically distinct IGF-1 receptor beta subunits.
Garofalo RS; Rosen OM
Mol Cell Biol; 1989 Jul; 9(7):2806-17. PubMed ID: 2476658
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.
Casella SJ; Han VK; D'Ercole AJ; Svoboda ME; Van Wyk JJ
J Biol Chem; 1986 Jul; 261(20):9268-73. PubMed ID: 3013881
[TBL] [Abstract][Full Text] [Related]
16. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants.
Schumacher R; Soos MA; Schlessinger J; Brandenburg D; Siddle K; Ullrich A
J Biol Chem; 1993 Jan; 268(2):1087-94. PubMed ID: 7678247
[TBL] [Abstract][Full Text] [Related]
17. An atypical insulin receptor with high affinity for insulin-like growth factors copurified with placental insulin receptors.
Jonas HA; Newman JD; Harrison LC
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4124-8. PubMed ID: 3012553
[TBL] [Abstract][Full Text] [Related]
18. Functional and immunological distinction between insulin-like growth factor I receptor subtypes in KB cells.
Garofalo RS; Barenton B
J Biol Chem; 1992 Jun; 267(16):11470-5. PubMed ID: 1317868
[TBL] [Abstract][Full Text] [Related]
19. Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors.
Perdue JF; LeBon TR; Kato J; Hampton B; Fujita-Yamaguchi Y
Endocrinology; 1991 Dec; 129(6):3101-8. PubMed ID: 1659523
[TBL] [Abstract][Full Text] [Related]
20. The human erythrocyte insulin-like growth factor I receptor: characterization and demonstration of ligand-stimulated autophosphorylation.
Catanese VM; Grigorescu F; King GL; Kahn CR
J Clin Endocrinol Metab; 1986 Apr; 62(4):692-9. PubMed ID: 3005355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
